Delytact (teserpaturev) is a genetically engineered oncolytic herpes simplex virus type 1 (HSV-1) that was approved for marketing in Japan earlier this year, and received pricing approval in ...

It's not the first therapy in the oncolytic virus class to be approved around the world, as that accolade went to Amgen's Imlygic (talimogene laherparepvec), which was cleared by the FDA for the ...

We know today that Wnt and a handful of other signalling systems (Notch, Hedgehog, TGFβ (transforming growth factor-β)–BMP (bone morphogenetic protein) and receptor tyrosine kinases) are major ...

today announced the acceptance of two abstracts that will be presented as posters a - Company significantly reduces cost structure with a realigned sales, marketing and operational infrastructure ...

It’s hard to say something nice about viruses, but Dr. Joaquín Martínez Martínez can. Dr. Martínez Martínez is a new aquatic ...